News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
329,003 Results
Type
Article (11435)
Company Profile (133)
Press Release (317422)
Multimedia
Podcasts (23)
Webinars (13)
Section
Business (93155)
Career Advice (375)
Deals (16504)
Drug Delivery (53)
Drug Development (32246)
Employer Resources (61)
FDA (8721)
Job Trends (7916)
News (153083)
Policy (12646)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1270)
Accelerated approval (14)
Adcomms (2)
Allergies (73)
Alliances (28697)
ALS (84)
Alzheimer's disease (838)
Antibody-drug conjugate (ADC) (208)
Approvals (9105)
Artificial intelligence (381)
Autoimmune disease (83)
Automation (35)
Bankruptcy (112)
Best Places to Work (7078)
BIOSECURE Act (10)
Biosimilars (103)
Biotechnology (79)
Bladder cancer (99)
Brain cancer (35)
Breast cancer (348)
Cancer (2916)
Cardiovascular disease (246)
Career advice (338)
Career pathing (11)
CAR-T (173)
CDC (3)
Cell therapy (458)
Cervical cancer (22)
Clinical research (29718)
Collaboration (1349)
Company closure (2)
Compensation (342)
Complete response letters (16)
COVID-19 (879)
CRISPR (51)
C-suite (631)
Cystic fibrosis (62)
Data (3661)
Denatured (19)
Depression (66)
Diabetes (266)
Diagnostics (3676)
Digital health (31)
Diversity (3)
Diversity, equity & inclusion (22)
Drug discovery (171)
Drug pricing (93)
Drug shortages (5)
Duchenne muscular dystrophy (109)
Earnings (33088)
Editorial (14)
Employer branding (4)
Employer resources (56)
Events (50314)
Executive appointments (763)
FDA (10804)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (7)
Funding (1072)
Gene editing (91)
Generative AI (31)
Gene therapy (309)
GLP-1 (378)
Government (1643)
Grass and pollen (3)
Guidances (249)
Healthcare (9945)
HIV (40)
Huntington's disease (12)
IgA nephropathy (41)
Immunology and inflammation (87)
Immuno-oncology (30)
Indications (81)
Infectious disease (1007)
Inflammatory bowel disease (97)
Inflation Reduction Act (12)
Influenza (60)
Intellectual property (167)
Interviews (52)
IPO (7029)
IRA (37)
Job creations (1211)
Job search strategy (294)
JPM (31)
Kidney cancer (10)
Labor market (27)
Layoffs (173)
Leadership (8)
Legal (2276)
Liver cancer (49)
Longevity (7)
Lung cancer (392)
Lymphoma (222)
Machine learning (28)
Management (21)
Manufacturing (572)
MASH (65)
Medical device (9469)
Medtech (9512)
Mergers & acquisitions (10229)
Metabolic disorders (580)
Multiple sclerosis (76)
NASH (2)
Neurodegenerative disease (133)
Neuropsychiatric disorders (36)
Neuroscience (1486)
Neurotech (1)
NextGen: Class of 2026 (3075)
Non-profit (2467)
Now hiring (9)
Obesity (224)
Opinion (147)
Ovarian cancer (109)
Pain (140)
Pancreatic cancer (126)
Parkinson's disease (160)
Partnered (25)
Patents (317)
Patient recruitment (299)
Peanut (25)
People (30040)
Pharmaceutical (36)
Pharmacy benefit managers (8)
Phase 1 (9372)
Phase 2 (11993)
Phase 3 (10533)
Pipeline (3220)
Policy (127)
Postmarket research (949)
Preclinical (2933)
Press Release (48)
Prostate cancer (157)
Psychedelics (7)
Radiopharmaceuticals (223)
Rare diseases (420)
Real estate (2915)
Recruiting (24)
Regulatory (11207)
Reports (23)
Research institute (1300)
Resumes & cover letters (49)
Rett syndrome (22)
RNA editing (3)
RSV (23)
Schizophrenia (85)
Series A (182)
Series B (137)
Service/supplier (7)
Sickle cell disease (44)
Special edition (4)
Spinal muscular atrophy (59)
Sponsored (23)
Startups (1963)
State (1)
Stomach cancer (3)
Supply chain (59)
Tariffs (36)
The Weekly (3)
Vaccines (374)
Venture capital (52)
Weight loss (118)
Women's health (60)
Worklife (8)
Date
Today (79)
Last 7 days (364)
Last 30 days (1310)
Last 365 days (18040)
2026 (1844)
2025 (18381)
2024 (20824)
2023 (22179)
2022 (27766)
2021 (28929)
2020 (27306)
2019 (25669)
2018 (19201)
2017 (16957)
2016 (15749)
2015 (17536)
2014 (12361)
2013 (9959)
2012 (10789)
2011 (10532)
2010 (8910)
Location
Africa (271)
Alabama (40)
Alaska (4)
Arizona (139)
Arkansas (11)
Asia (21861)
Australia (2966)
California (5732)
Canada (1916)
China (948)
Colorado (267)
Connecticut (306)
Delaware (199)
Europe (52879)
Florida (1003)
Georgia (231)
Hawaii (3)
Idaho (26)
Illinois (587)
India (45)
Indiana (398)
Iowa (15)
Japan (318)
Kansas (71)
Kentucky (12)
Louisiana (12)
Maine (31)
Maryland (800)
Massachusetts (4320)
Michigan (208)
Minnesota (373)
Mississippi (5)
Missouri (102)
Montana (27)
Nebraska (14)
Nevada (91)
New Hampshire (61)
New Jersey (2069)
New Mexico (20)
New York (1798)
North Carolina (867)
North Dakota (8)
Northern California (2660)
Ohio (200)
Oklahoma (18)
Oregon (24)
Pennsylvania (1345)
Puerto Rico (9)
Rhode Island (28)
South America (425)
South Carolina (56)
South Dakota (1)
Southern California (2248)
Tennessee (128)
Texas (954)
United States (22712)
Utah (188)
Vermont (1)
Virginia (144)
Washington D.C. (49)
Washington State (480)
West Virginia (3)
Wisconsin (108)
Wyoming (2)
329,003 Results for "max planck innovation gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Expanded Indication for Max 3™ Syringeless MR Injector from Bracco
November 26, 2025
·
11 min read
Press Releases
PEPperPRINT GmbH launches cLIFT technology for next-generation peptide microarrays
June 10, 2025
·
3 min read
Press Releases
Croma-Pharma GmbH Enters Strategic Distribution Partnership with Renellence in Canada
October 10, 2025
·
2 min read
BiondVax’s Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19
BiondVax Pharmaceuticals Ltd. provided encouraging updates related to the strategic research collaboration between BiondVax, the Max Planck Institute for Multidisciplinary Sciences, and the University Medical Center Göttingen towards the development of a pipeline of innovative alpaca–derived nanosized antibody therapies.
September 20, 2022
·
6 min read
Press Releases
Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01
October 8, 2025
·
6 min read
Press Releases
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
November 3, 2025
·
2 min read
Press Releases
MAX BioPharma and Revilico Announce Collaboration on Target Identification and Mechanistic Studies for Oxysterol Drug Candidates
August 7, 2025
·
3 min read
Press Releases
The Max Foundation (Max) Expands Collaboration with Novartis to Include Access to Innovative Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 6, 2024
·
3 min read
Press Releases
MAXONA PHARMACEUTICALS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR MAX-001
August 8, 2025
·
4 min read
Press Releases
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
November 5, 2025
·
3 min read
1 of 32,901
Next
